机译:动态宿主免疫和PD-L1/PD-1阻断功效:“淋巴细胞IFN-γ诱导PD-L1表达并促进卵巢癌进展”后的发展
Natl Hosp Org Kyoto Med Ctr;
Kyoto Univ;
Kindai Univ;
PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; EPITHELIAL OVARIAN; ANTI-PD-1 ANTIBODY; ANTITUMOR-ACTIVITY; TUMOR-CELLS; PEMBROLIZUMAB; CHEMOTHERAPY; BEVACIZUMAB; SAFETY;